Table 1.
Ganglionic AChR antibody in patients with dysautonomia and other disorders*
| Diagnostic Group | % seropositive |
|---|---|
| Autonomic disorders | |
| Subacute AAG | 50% |
| Paraneoplastic AAG | 25% |
| Postural tachycardia syndrome | 10 – 15% |
| Idiopathic gastrointestinal dysmotility | 5 – 10% |
| Diabetic autonomic neuropathy | < 10% |
| Multiple system atrophy (Shy-Drager) | 0 |
| Other disorders | |
| Lambert-Eaton syndrome | 5 –10% |
| Myasthenia gravis without thymoma | 1–2% |
| Paraneoplastic disorders with thymoma | 15 – 20% |
| Paraneoplastic disorders with SCLC | 3 – 5 % |
None of 150 healthy control subjects were seropositive for ganglionic AChR antibodies.